Sort
15,842 grants matching “pancreatic cancer”
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$877,842Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer
$877,760Subrata Sen · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA
Mouse Models of Gastrointestinal Cancer
$877,698Joanna Louise Groden · Ohio State University · U01 · FY2008 · CA
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk
$877,320Yu Chen · New York University School Of Medicine · R01 · FY2016 · CA
Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images
$875,504Debiao Li · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
$875,414Randall Brand · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · CA
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
$874,817William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2021 · HL
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2019 · HL
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2020 · HL
WASHINGTON UNIVERSITY HUMAN TUMOR ATLAS RESEARCH CENTER
$874,677Li Ding · Washington University · U2C · FY2023 · CA
Metabolic Studies of Mouse Models of Obesity and Diabetes
$874,327Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2010 · DK
Studying factors controlling cancer progression and immune recognition in mouse models
$871,800Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2022 · CA
Ultra-high content analyses of circulating and solid tumor cells: A diagnostic reference system for disease burden
$871,668Michel Nederlof · Quantitative Imaging Systems, Llc · R44 · FY2022 · CA
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
$869,665Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mouse Models of Gastrointestinal Cancer
$868,895Joanna Louise Groden · Ohio State University · U01 · FY2007 · CA
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
$868,844Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2019 · CA
EARLY HEPATIC DISSEMINATION OF PANCREATIC CANCER: EFFECTIVE TREATMENT BY SYSTEMIC CHEMOTHERAPY-ENHANCED ALPHA-PARTICLE RADIOTHERAPY
$867,712The Johns Hopkins University · · FY2024 · Defense Health Agency
Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$867,444Sanku Mallik · North Dakota State University · P20 · FY2016 · GM
RAIT of Pancreatic Cancer with Humanized PAM4
$866,940Ctr For Molecular Medicine/Immunology · R01 · FY2004 · CA
Role of FH loss in development of HLRCC heriditary kidney cancer
$866,305Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Drug Development Core
$866,135Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2008 · CA
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
$865,924Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Targeting undruggable RAS for cancer treatment
$865,656Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2024 · CA
Clinical Trials for Imaging and Therapy
$864,904Suzanne Elizabeth Lapi · Proteogenomics Research Instit/Sys/ Med · P01 · FY2022 · CA